These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8221663)

  • 1. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
    Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
    Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of p53 gene mutations in primary neuroblastomas.
    Vogan K; Bernstein M; Leclerc JM; Brisson L; Brossard J; Brodeur GM; Pelletier J; Gros P
    Cancer Res; 1993 Nov; 53(21):5269-73. PubMed ID: 8221661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
    Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
    Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours.
    Kovar H; Auinger A; Jug G; Aryee D; Zoubek A; Salzer-Kuntschik M; Gadner H
    Oncogene; 1993 Oct; 8(10):2683-90. PubMed ID: 8378080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification.
    Imamura J; Bartram CR; Berthold F; Harms D; Nakamura H; Koeffler HP
    Cancer Res; 1993 Sep; 53(17):4053-8. PubMed ID: 8358734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene mutation spectrum in human unknown primary tumors.
    Bar-Eli M; Abbruzzese JL; Lee-Jackson D; Frost P
    Anticancer Res; 1993; 13(5A):1619-23. PubMed ID: 8239543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations in bladder carcinoma cell lines.
    Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
    Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
    Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
    Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma.
    Felix CA; Kappel CC; Mitsudomi T; Nau MM; Tsokos M; Crouch GD; Nisen PD; Winick NJ; Helman LJ
    Cancer Res; 1992 Apr; 52(8):2243-7. PubMed ID: 1559227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary malignant lymphoma of the brain: demonstration of the p53 gene mutations by PCR-SSCP analysis and immunohistochemistry.
    Koga H; Zhang S; Ichikawa T; Washiyama K; Kuroiwa T; Tanaka R; Kumanishi T
    Noshuyo Byori; 1994; 11(2):151-5. PubMed ID: 7894617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 and RAS gene mutations in multiple myeloma.
    Portier M; Molès JP; Mazars GR; Jeanteur P; Bataille R; Klein B; Theillet C
    Oncogene; 1992 Dec; 7(12):2539-43. PubMed ID: 1461658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.
    Van Leeuwen IS; Hellmèn E; Cornelisse CJ; Van den Burgh B; Rutteman GR
    Anticancer Res; 1996; 16(6B):3737-44. PubMed ID: 9042250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
    Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
    Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying levels of p53 mutation in mouse skin tumors.
    Verkler TL; Couch LH; Howard PC; Parsons BL
    Environ Mol Mutagen; 2005 Jun; 45(5):427-34. PubMed ID: 15662716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y; Hayashi K; Hirohashi S; Sekiya T
    Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
    Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN
    Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.